CapsoVision (CV) Operating Leases (2024 - 2026)
CapsoVision (CV) posted Operating Leases of $477000.0 for Q4 2025, down 51.23% sequentially from $978000.0 in Q3 2025, and down 61.47% YoY from $1.2 million in Q4 2024.
CapsoVision (CV) Operating Leases (2024 - 2026) Analysis & Trends
CapsoVision has reported Operating Leases for 2 years, with the latest figure at $477000.0 in Q4 2025.
- Quarterly Operating Leases fell 61.47% year-over-year to $477000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $477000.0 (down 61.47% YoY) and the FY2025 annual result came in at $477000.0, down 61.47% from the prior year.
- Operating Leases eased to $477000.0 in Q4 2025 per CV's latest filing, from $978000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $1.2 million in Q4 2024 and troughed at $477000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | CapsoVision | 295.13 Mn | 286.05 Mn | 1.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 687,000.00 |
| Dec 31, 2025 | 477,000.00 |
| Sep 30, 2025 | 978,000.00 |
| Jun 30, 2025 | 687,000.00 |
| Dec 31, 2024 | 1.24 Mn |